文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

夹竹桃麻素抑制NF-κB通路并减轻大鼠失血性休克模型肺损伤

Apocynin suppressed the nuclear factor-κB pathway and attenuated lung injury in a rat hemorrhagic shock model.
PubMed 文献 · J Trauma Acute Care Surg · 2017-01-01
一句话结论大鼠失血性休克模型中,腹腔注射高剂量夹竹桃麻素(40 mg/kg)抑制Nox2与NF-κB通路、减轻肺损伤,并将72小时生存率从30%提高至70%,低剂量(20 mg/kg)无效。

本研究在大鼠失血性休克模型中探讨NADPH氧化酶抑制剂夹竹桃麻素的作用。雄性Sprague-Dawley大鼠(290–340 g)放血维持平均动脉压20–25 mm Hg共40分钟,随后回输所放血液,并腹腔注射载体、低剂量夹竹桃麻素(20 mg/kg)或高剂量夹竹桃麻素(40 mg/kg)。假手术组、休克组、低剂量组和高剂量组72小时生存率分别为100%(5/5)、30%(3/10)、40%(4/10)和70%(7/10)。高剂量夹竹桃麻素降低肺组织gp91-phox表达、Nox活性、丙二醛水平、p-IκB-α表达、NF-κB p65 DNA结合活性、TNF-α与IL-6基因表达及MPO活性,并减轻肺组织学损伤;低剂量未见这些获益。

要点

  • 大鼠失血性休克(平均动脉压20–25 mm Hg维持40分钟)后,高剂量夹竹桃麻素40 mg/kg腹腔注射组72小时生存率为70%(7/10),休克对照组为30%(3/10)。
  • 低剂量夹竹桃麻素20 mg/kg腹腔注射组72小时生存率为40%(4/10),未显示高剂量组的获益。
  • 高剂量夹竹桃麻素降低肺组织gp91-phox表达、Nox活性及丙二醛水平,提示抑制Nox2与脂质过氧化。
  • 高剂量夹竹桃麻素降低肺组织p-IκB-α表达、NF-κB p65 DNA结合活性、TNF-α与IL-6基因表达及MPO活性,并减轻组织学肺损伤。
  • 假手术组72小时生存率为100%(5/5);生存观察与肺组织检测为两批独立大鼠,肺组织于休克诱导后6小时取材。

适用人群与场景

  • 雄性Sprague-Dawley大鼠,体重290–340 g,失血性休克模型(放血维持平均动脉压20–25 mm Hg共40分钟,随后回输所放血液)

处置流程与药物剂量

  • 失血性休克大鼠在回输所放血液时腹腔注射夹竹桃麻素高剂量40 mg/kg或低剂量20 mg/kg,对照给予载体。
  • 生存观察持续72小时;另一批大鼠于休克诱导后6小时处死,检测肺组织指标。

研究设计与关键结果

  • 研究类型为大鼠实验研究;假手术组、休克组、休克+低剂量夹竹桃麻素组、休克+高剂量夹竹桃麻素组72小时生存率分别为100%(5/5)、30%(3/10)、40%(4/10)、70%(7/10)。
  • 高剂量夹竹桃麻素降低失血性休克与复苏期间肺组织gp91-phox表达、Nox活性及丙二醛水平。
  • 高剂量夹竹桃麻素降低肺组织p-IκB-α表达、NF-κB p65 DNA结合活性、TNF-α与IL-6基因表达及MPO活性,并减轻组织学肺损伤。
  • 低剂量夹竹桃麻素未显示上述获益。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠失血性休克模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论仅基于大鼠失血性休克模型,作者报告高剂量夹竹桃麻素抑制Nox2表达与Nox活性、减少脂质过氧化、抑制NF-κB通路及后续促炎细胞因子转录、减轻休克与复苏期间肺损伤;未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The aim of this study was to investigate whether a nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) inhibitor, apocynin, reduces reactive oxygen species (ROS) production, suppresses the nuclear factor κB (NF-κB) pathway, attenuates lung injury, and improves survival in rat hemorrhagic shock (HS) model.

METHODS: Blood was drawn from male Sprague-Dawley rats (290-340 g) to maintain a mean arterial pressure of 20-25 mm Hg for 40 minutes. The rats were resuscitated with the drawn blood, and a vehicle (HS), a low dose of apocynin (20 mg/kg, LD-Apo), or a high dose of apocynin (40 mg/kg, HD-Apo) was administered intraperitoneally. The survival of the rats was observed for 72 hours. Then, a separated set of rats was euthanized at 6 hours post-HS induction. We measured gp91-phox (Nox2) expression, Nox activity, cytoplasmic phosphorylated inhibitor κB-α (p-IκB-α) expression, NF-κB p65 DNA-binding activity, tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) gene expressions, malondialdehyde (MDA) level, myeloperoxidase (MPO) activity, and histological damage in the lung tissues.

RESULTS: The survival rates of the sham, HS, HS + LD-Apo, and HS + HD-Apo groups were 100% (5/5), 30% (3/10), 40% (4/10), and 70% (7/10), respectively. A high dose of apocynin decreased gp91-phox expression, Nox activity, and MDA level in the lung tissues during HS and resuscitation. It also decreased p-IκB-α expression, NF-κB p65 DNA-binding activity, TNF-α and IL-6 gene expressions, and MPO activity in the lung tissues and attenuated histological lung injuries. However, a low dose of apocynin failed to show these benefits.

CONCLUSIONS: The administration of a high dose of apocynin inhibited Nox2 expression and Nox activity, reduced lipid peroxidation, suppressed the NF-κB pathway and subsequent pro-inflammatory cytokines transcription in the lung tissues, and attenuated lung injury during HS and resuscitation in rats.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Choi SH, Suh GJ, Kwon WY, et al. Apocynin suppressed the nuclear factor-κB pathway and attenuated lung injury in a rat hemorrhagic shock model. J Trauma Acute Care Surg. 2017. PMID: 28030501. doi:10.1097/TA.0000000000001337

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。